Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA127 for Engraftment in Pediatric Cord Blood Transplant
NCT01554254Phase 2Withdrawn
- Sponsor
- Tarix Pharmaceuticals Ltd.
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of talfirastide in hematologic malignancy, Inherited metabolic disorder (IMD), sponsored by Tarix Pharmaceuticals Ltd.. Planned start Mar 2012; status: withdrawn.
02
Drugs
talfirastide
03
Conditions
hematologic malignancyInherited metabolic disorder (IMD)
Beyond the preview
Go deeper on NCT01554254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554254.